14 Best GARP Stocks to Buy According to Analysts

12. Humana Inc. (NYSE:HUM)

On February 25, Barclays lowered its price recommendation on Humana Inc. (NYSE:HUM) to $176 from $245. The firm reiterated an Equal Weight rating on the shares. It said it is “incrementally cautious” about the company’s expectation that Individual Medicare Advantage margins will double.

A February 14 Bloomberg report said Humana acquired Florida-based clinic operator MaxHealth. The company plans to integrate MaxHealth into its CenterWell Senior Primary Care division. This move expands Humana’s footprint in primary care for seniors. Financial terms were not disclosed. Reports suggested the deal was valued at around $1 billion.

MaxHealth operates more than 80 clinics across West and South Florida. It serves over 120,000 patients. The acquisition supports Humana’s broader effort to expand its primary care network. This comes at a time when its Medicare Advantage business faces pressure from rising care costs and tighter government reimbursement rates.

Humana Inc. (NYSE:HUM) provides insurance services and healthcare services through its CenterWell platform. The company operates through two main segments: Insurance and CenterWell.